The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Biosimilar DMARDs offer cost-effective and improved outcomes over leflunomide for RA patients unresponsive to methotrexate. The study used a Markov model with data from 25,099 RA patients to simulate ...

Announcing a new publication for Acta Materia Medica journal. Diacerein, an anthraquinone derivative, is emerging as a promising disease-modifying agent in rheumatoid arthritis (RA), because of its ...

Gender-based differences were identified in the clinical characteristics and time to initiation of the first biologic or targeted synthetic disease-modifying antirheumatic drug (b/ts DMARD) among ...

Medically reviewed by Anita C. Chandrasekaran, MD Key Takeaways Methotrexate may cause modest weight gain, especially if you are underweight when you start treatment.If you gain weight on methotrexate ...

Researchers conducted an open-label randomised trial including 65 adults with active RA (mean age, 59.1 years; median disease duration, 13 years) across seven hospitals in Netherlands between February ...

Subcutaneous tocilizumab, alone or with methotrexate, showed superior efficacy over methotrexate monotherapy in treating rheumatoid arthritis in Chinese patients. The trial demonstrated higher ACR20 ...